Stock PHXM PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News PHAXIAM Therapeutics S.A.

Equities

PHXM

FR001400K4B1

End-of-day quote Euronext Paris
Other stock markets
 06:00:00 2024-05-13 pm EDT 		5-day change 1st Jan Change
3.025 EUR +0.83% Intraday chart for PHAXIAM Therapeutics S.A. +4.31% -34.24%
Apr. 15 Phaxiam initiates trial in infective endocarditis CF
Apr. 15 PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PHAXIAM provides Business and Financial Update for the First Quarter of 2024
GL
Phaxiam initiates trial in infective endocarditis
CF
PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus
GL
PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus
CI
PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)
GL
Transcript : PHAXIAM Therapeutics S.A., Q4 2023 Earnings Call, Mar 21, 2024
PHAXIAM Announces 2023 Full-Year Results and Provides Business Update
GL
PHAXIAM Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
PHAXIAM Therapeutics Completes Delisting of ADS From Nasdaq
MT
Phaxiam Therapeutics Delists from Nasdaq Capital Market
MT
PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
GL
PHAXIAM Therapeutics S.A.(NasdaqCM:PHXM) dropped from NASDAQ Composite Index
CI
ADRs Slump, Quoin Pharmaceuticals Ltd. Declines 48.3%
DJ
ADRs Slump; Jianpu Technology Declines 62%
DJ
Global markets live: BAE Systems, HSBC, Nvidia, Tesla, Boeing...
Our Logo
Phaxiam to delist ADS from Nasdaq in March
CF
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
GL
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
AQ
PHAXIAM Therapeutics S.A.(NasdaqCM:PHXM) added to NASDAQ Composite Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. News PHAXIAM Therapeutics S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW